ArticleTranslational psychiatry2026
Phenotyping antidepressant treatment response with deep learning in electronic health records.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Automated classification of clinical diagnoses in electronic health records using transformer.PloS one · 2025Article
- AI-assisted prediction of differential response to antidepressant classes using electronic health records.NPJ digital medicine · 2023Article
- Investigating genetic overlap between antidepressant and lithium response and treatment resistance in major depressive disorder.Research square · 2023Article
- Translating clinical notes into quantitative measures-a real-world observation on the response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records.Frontiers in pharmacology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Efficient, accurate phenotyping for antidepressant treatment response in electronic health records (EHRs) could facilitate precision psychiatry applications but remains a challenge. Increasingly, artificial intelligence methods using deep learning applied to clinical data have shown promise in complex classification problems. Here, we systematically evaluate the performance of eight deep learning-based language models in classifying response to antidepressants in a large real-world healthcare setting. We obtained data spanning 1990-2018 for adults with depression and a co-occurring antidepressant prescription from the EHR data warehouse of the Mass General Brigham healthcare system (n = 111,563). Clinical note sets (n = 3996) were collected for 4-12 weeks after antidepressant initiation, and were manually reviewed to classify response status as "improved" or "no evidence of improvement" in depression symptoms for model development and evaluation. The phenotyping models performed well, with the majority having areas under the receiver operator curve (AUROC) exceeding 0.80. For example, BERT-large with sliding window had an AUROC = 0.84 and PPV = 0.80 at a specificity of 0.87. Our results indicate that deep learning language models applied to EHR data can accurately classify antidepressant response in a real-world healthcare setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.